Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070)

Seoulin Bioscience Revenue

Seoulin Bioscience had revenue of 22.87B KRW in the quarter ending September 30, 2025, with 33.48% growth. This brings the company's revenue in the last twelve months to 76.74B, down -6.52% year-over-year. In the year 2024, Seoulin Bioscience had annual revenue of 75.41B, down -15.81%.

• Revenue (ttm): 76.74B
• Revenue Growth: -6.52%
• P/S Ratio: 0.76
• Revenue / Employee: 737.87M
• Employees: 104
• Market Cap: 58.17B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	75.41B	-14.16B	-15.81%
Dec 31, 2023	89.57B	-15.14B	-14.46%
Dec 31, 2022	104.71B	24.17B	30.01%
Dec 31, 2021	80.54B	15.45B	23.74%
Dec 31, 2020	65.09B	10.68B	19.62%